COMORBIDITIES OF AUTOIMMUNE BULLOUS DERMATOSES IN NORTH-EASTERN ROMANIA

  • Ioana Adriana POPESCU “Sf. Spiridon” County Clinical Emergency Hospital Iasi
  • D. VATA “Sf. Spiridon” County Clinical Emergency Hospital Iasi
  • Doinita TEMELIE OLINICI “Sf. Spiridon” County Clinical Emergency Hospital Iasi
  • B.M. TARCAU “Sf. Spiridon” County Clinical Emergency Hospital Iasi
  • Adriana Ionela PATRASCU “Sf. Spiridon” County Clinical Emergency Hospital Iasi
  • Dumitrita Lenuta GUGULUS “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Madalina MOCANU “Sf. Spiridon” County Clinical Emergency Hospital Iasi
  • Laura GHEUCA-SOLOVASTRU “Sf. Spiridon” County Clinical Emergency Hospital Iasi

Abstract

Autoimmune bullous dermatoses (ABDs) are associated with a variety of systemic comorbidities, determined either by skin pathology or by the effects of systemic corticosteroid treatment. The most important comorbidities encountered in autoimmune bullous dermatoses belong to the cardiovascular, neurological, psychiatric, metabolic or infectious sphere. Materials and methods: We performed a retrospective observational study used the Minimum Basic Data Set of hospital discharges to review records of patients admitted to Sf Spiridon Iasi public hospital between 2015 and 2019 with a diagnosis of any autoimmune bullous disorder. The objectives were to describe the triggering factors and the comorbidity profile of patients with autoimmune bullous dermatoses. Results: The study included 225 patients, the most common autoimmune bullous dermatosis being pemphigus vulgaris. Some comorbidities, diabetes mellitus, or high blood pressure are more often found in patients with bullous pemphigoid, while vulgar pemphigus is more commonly associated with other diseases of autoimmune etiology (autoimmune thyroiditis, vitiligo). Conclusions: Evaluation of triggering factors and comorbidities before starting treatment may assist in controlling the disease more swiftly and reducing the side effects of treatment in the management of ABDs.

Author Biographies

Ioana Adriana POPESCU, “Sf. Spiridon” County Clinical Emergency Hospital Iasi

“Grigore T. Popa” University of Medicine and Pharmacy Iasi
Faculty of Medicine

D. VATA, “Sf. Spiridon” County Clinical Emergency Hospital Iasi

“Grigore T. Popa” University of Medicine and Pharmacy Iasi
Faculty of Medicine

Doinita TEMELIE OLINICI, “Sf. Spiridon” County Clinical Emergency Hospital Iasi

“Grigore T. Popa” University of Medicine and Pharmacy Iasi
Faculty of Medicine

B.M. TARCAU, “Sf. Spiridon” County Clinical Emergency Hospital Iasi

“Grigore T. Popa” University of Medicine and Pharmacy Iasi
Faculty of Medicine

Adriana Ionela PATRASCU, “Sf. Spiridon” County Clinical Emergency Hospital Iasi

“Grigore T. Popa” University of Medicine and Pharmacy Iasi
Faculty of Medicine

Dumitrita Lenuta GUGULUS, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine

Madalina MOCANU, “Sf. Spiridon” County Clinical Emergency Hospital Iasi

“Grigore T. Popa” University of Medicine and Pharmacy Iasi
Faculty of Medicine

Laura GHEUCA-SOLOVASTRU, “Sf. Spiridon” County Clinical Emergency Hospital Iasi

“Grigore T. Popa” University of Medicine and Pharmacy Iasi
Faculty of Medicine

References

1. Rokni AM, Ayasse M, Ahmed A, Guggina L, Kantor RW, Silverberg JI. Association of autoimmune blistering disease, and specifically, pemphigus vulgaris, with cardiovascular disease and its risk factors: a systematic review and meta-analysis. Arch Dermatol Res 2023; 315(2): 207-213 / doi: 10.1007/s00403-022-02346-y
2. Sánchez-García V, Pérez-Alcaraz L, Belinchón-Romero I, Ramos-Rincón J-M. Comorbidities in Patients with Autoimmune Bullous Disorders: Hospital-Based Registry Study. Life 2022; 12(4):595. https://doi.org/10.3390/life12040595
3. Kang H, Wu M, Feng J, et al. Ocular surface disorders affect quality of life in patients with autoimmune blistering skin diseases: a cross-sectional study. BMC Ophthalmol. 2022;22(1):437. Published 2022 Nov 15. doi:10.1186/s12886-022-02663-w
4. Akarsu S, Özbağçivan Ö, Dolaş N, Aktan Ş. Possible triggering factors and comorbidities in newly diagnosed autoimmune bullous diseases. Turk J Med Sci. 2017 Jun 12;47(3):832-840. doi: 10.3906/sag-1602-99.
5. Ljubojevic S, Lipozenčić J. Autoimmune bullous diseases associations. Clin Dermatol. 2012;30(1):17-33. doi: 10.1016/j.clindermatol.2011.03.006
6. Kang M, Bilgic A, Radjenovic M, Murrell D. Osteoporosis and Bone Health in Autoimmune Blistering Skin Disease – An Evidenced Based Review. Journal of the European Academy of Dermatology and Venereology. 2020 / doi:10.1111/jdv.16334
7. Lai O, Recke A, Zillikens D, Kasperkiewicz M. Influence of cigarette smoking on pemphigus – a systematic review and pooled analysis of the literature. J Eur Acad Dermatol Venereol 2018; 32: 1256-1262 / doi: 10.1111/jdv.14886.
8. Bastuji-Garin S, Joly P, Lemordant P, et al. French Study Group for Bullous Diseases. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol. 2011; 131(3): 637-643 / doi: 10.1038/jid.2010.301.
9. Lütgerath C, Sadik CD, van Beek N. Triggerfaktoren bullöser Autoimmundermatosen (Trigger factors associated with bullous autoimmune dermatoses). Dermatologie (Heidelb) 2022; 74(12): 948-954 / doi: 10.1007/s00105-023-05249-9.
Published
2024-03-29
Section
INTERNAL MEDICINE - PEDIATRICS